Getein Biotech, Inc (603387.SS)
CNY 8.59
(-0.12%)
CNY 8.59
(-0.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 306.58 Million CNY | -45.57% |
| 2022 | 563.25 Million CNY | 24.4% |
| 2021 | 452.78 Million CNY | 19.79% |
| 2020 | 377.99 Million CNY | -5.24% |
| 2019 | 398.91 Million CNY | 41.06% |
| 2018 | 282.79 Million CNY | 26.76% |
| 2017 | 223.09 Million CNY | 46.18% |
| 2016 | 152.61 Million CNY | 36.5% |
| 2015 | 111.81 Million CNY | 38.21% |
| 2014 | 80.89 Million CNY | 16.54% |
| 2013 | 69.41 Million CNY | 220.07% |
| 2012 | 21.68 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 49.43 Million CNY | -3.19% |
| 2024 Q1 | 100.43 Million CNY | 76.3% |
| 2024 Q2 | 66.22 Million CNY | -34.06% |
| 2023 FY | 306.58 Million CNY | -45.57% |
| 2023 Q3 | 61.32 Million CNY | 23.29% |
| 2023 Q4 | 56.96 Million CNY | -7.1% |
| 2023 Q1 | 138.56 Million CNY | 519.91% |
| 2023 Q2 | 49.73 Million CNY | -64.11% |
| 2022 Q1 | 243.83 Million CNY | 56.8% |
| 2022 FY | 563.25 Million CNY | 24.4% |
| 2022 Q3 | 162.35 Million CNY | 20.51% |
| 2022 Q2 | 134.71 Million CNY | -44.75% |
| 2022 Q4 | 22.35 Million CNY | -86.23% |
| 2021 Q3 | 102.23 Million CNY | -16.37% |
| 2021 Q2 | 122.24 Million CNY | 67.93% |
| 2021 FY | 452.78 Million CNY | 19.79% |
| 2021 Q1 | 72.79 Million CNY | -43.85% |
| 2021 Q4 | 155.5 Million CNY | 52.09% |
| 2020 Q2 | 60.53 Million CNY | 18.26% |
| 2020 Q4 | 129.64 Million CNY | -5.11% |
| 2020 FY | 377.99 Million CNY | -5.24% |
| 2020 Q1 | 51.18 Million CNY | -68.8% |
| 2020 Q3 | 136.62 Million CNY | 125.69% |
| 2019 Q2 | 82.58 Million CNY | -15.86% |
| 2019 Q4 | 164.05 Million CNY | 203.08% |
| 2019 FY | 398.91 Million CNY | 41.06% |
| 2019 Q3 | 54.12 Million CNY | -34.45% |
| 2019 Q1 | 98.14 Million CNY | 32.87% |
| 2018 Q1 | 76.06 Million CNY | 7.39% |
| 2018 FY | 282.79 Million CNY | 26.76% |
| 2018 Q4 | 73.86 Million CNY | 26.16% |
| 2018 Q3 | 58.55 Million CNY | -20.94% |
| 2018 Q2 | 74.05 Million CNY | -2.65% |
| 2017 Q1 | 45.01 Million CNY | -6.61% |
| 2017 Q2 | 53.67 Million CNY | 19.23% |
| 2017 Q3 | 53.57 Million CNY | -0.18% |
| 2017 Q4 | 70.83 Million CNY | 32.21% |
| 2017 FY | 223.09 Million CNY | 46.18% |
| 2016 Q3 | 32.51 Million CNY | -17.95% |
| 2016 Q1 | 32.27 Million CNY | 0.0% |
| 2016 Q2 | 39.62 Million CNY | 22.78% |
| 2016 Q4 | 48.19 Million CNY | 48.24% |
| 2016 FY | 152.61 Million CNY | 36.5% |
| 2015 Q1 | 24.59 Million CNY | 0.0% |
| 2015 FY | 111.81 Million CNY | 38.21% |
| 2014 FY | 80.89 Million CNY | 16.54% |
| 2013 FY | 69.41 Million CNY | 220.07% |
| 2012 FY | 21.68 Million CNY | 0.0% |